Search research articles
Contact Us
Filters
Showing results (41-50 of 497) with videos related to
Page
of 50
Sort By:
BMC Cancer
|
January 1, 2020
Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence
Luigi Celio, Erminio Bonizzoni, Emma Zattarin, et al.
Tumori
|
February 19, 2020
Recurrent thrombosis followed by Lazarus response in <i>ROS1</i> rearranged NSCLC treated with crizotinib: a case report
Teresa Beninato, Giuseppe Lo Russo, Marina Chiara Garassino, et al.
Drug Design, Development and Therapy
|
July 28, 2016
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy
Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Cancer Discovery
|
November 23, 2016
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Claudio Vernieri, Stefano Casola, Marco Foiani, et al.
Future Oncology (London, England)
|
October 26, 2013
Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity
Elena Verzoni, Filippo de Braud, Francesca Fabiani, et al.
Therapeutic Advances in Urology
|
April 2, 2015
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib
Paolo Grassi, Elena Verzoni, Luca Porcu, et al.
Pharmacogenomics
|
July 26, 2018
Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies
Alessandra Raimondi, Federico Nichetti, Giorgia Peverelli, et al.
Breast Care (Basel, Switzerland)
|
February 24, 2017
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature
Arpine Gevorgyan, Giacomo Bregni, Giulia Galli, et al.
Cancer Treatment Reviews
|
December 11, 2019
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer
Filippo Pietrantonio, Giovanni Randon, Dario Romagnoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
Preoperative chemotherapy in non-small-cell lung cancer: nothing new in N2 disease
Tommaso De Pas, Ugo Pastorino, Lorenzo Spaggiari, et al.
Page
of 50
Search research articles
Search
Showing results (41-50 of 497) with videos related to
Sort By:
Page
of 50
BMC Cancer
|
January 1, 2020
Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence
Luigi Celio, Erminio Bonizzoni, Emma Zattarin, et al.
Tumori
|
February 19, 2020
Recurrent thrombosis followed by Lazarus response in <i>ROS1</i> rearranged NSCLC treated with crizotinib: a case report
Teresa Beninato, Giuseppe Lo Russo, Marina Chiara Garassino, et al.
Drug Design, Development and Therapy
|
July 28, 2016
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy
Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Cancer Discovery
|
November 23, 2016
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Claudio Vernieri, Stefano Casola, Marco Foiani, et al.
Future Oncology (London, England)
|
October 26, 2013
Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity
Elena Verzoni, Filippo de Braud, Francesca Fabiani, et al.
Therapeutic Advances in Urology
|
April 2, 2015
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib
Paolo Grassi, Elena Verzoni, Luca Porcu, et al.
Pharmacogenomics
|
July 26, 2018
Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies
Alessandra Raimondi, Federico Nichetti, Giorgia Peverelli, et al.
Breast Care (Basel, Switzerland)
|
February 24, 2017
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature
Arpine Gevorgyan, Giacomo Bregni, Giulia Galli, et al.
Cancer Treatment Reviews
|
December 11, 2019
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer
Filippo Pietrantonio, Giovanni Randon, Dario Romagnoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
Preoperative chemotherapy in non-small-cell lung cancer: nothing new in N2 disease
Tommaso De Pas, Ugo Pastorino, Lorenzo Spaggiari, et al.
Page
of 50